Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits

  • Rius-Bonet, Julia
  • Macip, Salvador
  • Closa, Daniel
  • Massip-Salcedo, Marta
Intermittent fasting (IF) has proven to be a feasible dietary intervention for the wider population. The recent increase in IF clinical trials highlights its potential effects on health, including changes in body composition, cardiometabolic status, and aging. Although IF may have clinical applications in different populations, studies suggest there may be sex-specific responses in parameters such as body composition or glucose and lipid metabolism. Here, the existing literature on IF clinical trials is summarized, the application of IF in both disease prevention and management is discussed, and potential disparities in response to this type of diet between men and women are assessed. Moreover, the potential mechanisms that may be contributing to the sexually dimorphic response, such as age, body composition, tissue distribution, or sex hormones are investigated. This review underscores the need to further study these sex-specific responses to IF to define the most effective time frames and length of fasting periods for men and women. Tailoring IF to specific populations with a personalized approach may help achieve its full potential as a lifestyle intervention with clinical benefits., This work was supported by project PI20/00328 from Instituto de Salud Carlos III and the M.C. Andreu Memorial Fund. J.R.-B. was supported by a doctoral grant from the Universitat Oberta de Catalunya., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The multiomics blueprint of the individual with the most extreme lifespan

  • Santos-Pujol, Eloy
  • Noguera-Castells, Aleix
  • Casado-Pelaez, Marta
  • García-Prieto, Carlos A
  • Vasallo, Claudia
  • Campillo-Marcos, Ignacio
  • Quero-Dotor, Carlos
  • Crespo-García, Eva
  • Bueno-Costa, Alberto
  • Setién, Fernando
  • Ferrer, Gerardo
  • Davalos, Veronica
  • Mereu, Elisabetta
  • Pluvinet, Raquel
  • Arribas, Carles
  • Torre, Carolina de la
  • Villavicencio, Francisco
  • Sumoy, Lauro
  • Granada, Isabel
  • Coles, Natalie S
  • Acha, Pamela
  • Solé, Francesc
  • Mallo, Mar
  • Mata, Caterina
  • Peregrina, Sara
  • Gabaldón, Toni
  • Llirós, Marc
  • Pujolassos, Meritxell
  • Carreras-Torres, Robert
  • Lluansí, Aleix
  • García-Gil, Librado Jesús
  • Aldeguer, Xavier
  • Samino, Sara
  • Torné, Pol
  • Ribalta, Josep
  • Guardiola, Montse
  • Amigó, Núria
  • Yanes, Oscar
  • Martínez, Paula
  • Sánchez-Vázquez, Raúl
  • Blasco, Maria A
  • Oviedo, Jose
  • Lemos, Bernardo
  • Rius-Bonet, Julia
  • Torrubiano, Marta
  • Massip-Salcedo, Marta
  • Khidir, Kamal A
  • Cao, Thong Huy
  • Quinn, Paulene A
  • Jones, Donald J L
  • Macip, Salvador
  • Brigos-Barril, Eva
  • Moldes, Mauricio
  • Barteri, Fabio
  • Muntané, Gerard
  • Laayouni, Hafid
  • Navarro, Arcadi
  • Esteller, Manel
Extreme human lifespan, exemplified by supercentenarians, presents a paradox in understanding aging: despite advanced age, they maintain relatively good health. To investigate this duality, we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome, comparing the results with larger matched cohorts. The emerging picture highlights different pathways attributed to each process: the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis, whereas absence of typical age-associated diseases is associated with rare European-population genetic variants, low inflammation levels, a rejuvenated bacteriome, and a younger epigenome. These findings provide a fresh look at human aging biology, suggesting biomarkers for healthy aging, and potential strategies to increase life expectancy. The extrapolation of our results to the general population will require larger cohorts and longitudinal prospective studies to design potential anti-aging interventions., We thank Yoana Veselinova for the drawing of the graphical abstract. Research in the M.E. group is funded by the CERCA Programme/Generalitat de Catalunya (MCIN/AEI/10.13039/501100011033/); the European Regional Development Fund, “A way to make Europe” ERDF (project PID2021-125282OB-I00 and PID2024-159192OB-I00); Departament de Recerca i Universitats/Generalitat de Catalunya (2021 SGR 01494); European Union under THRIVE grant agreement no. 101136622; “La Caixa” Research Foundation; and the Cellex Foundation (CEL007). E.S.-P. is a fellow of the Spanish Ministry of Science, Innovation and Universities, under FPI contract no. PRE2022-105015. G.F. is a recipient of Ayuda Investigador AECC 2023 (INVES234765FERR), Fundación Científica AECC. C.Q.-D. is a fellow of the Spanish Ministry of Science, Innovation and Universities, under FPU contract no. FPU22/01655. E.M.’s work in this publication was supported by the Ramón y Cajal fellowship RYC2021-032359-I, funded by the Spanish Ministry of Science and the Catalan Agency for Management of University and Research Grants (AGAUR, 2021 SGR 01586). Research in the A.N. group is supported by the I+D+i project PID2021-127792NB-I00, funded by MCIN/AEI/10.13039/501100011033 (FEDER Una manera de hacer Europa), and “Unidad de Excelencia María de Maeztu,” funded by the AEI (CEX2018-000792-M) and Departament de Recerca i Universitats de la Generalitat de Catalunya (GRC 2021 SGR 0467). Research in the R.C.-T.. group is funded by the Departament de Recerca i Universitats/Generalitat de Catalunya (2021 SGR 01366). Research in the S.M. group was supported by the Instituto de Salud Carlos III (PI20/00328) and the M. C. Andreu Memorial Fund. J.R.-B. was supported by a doctoral grant from the Universitat Oberta de Catalunya. Research in the M.A.B. laboratory is funded by the European Union, project ERC-AvG Shelterins (GA 882385), Horizon 2020 Programme. The mass spectrometry work was supported by the John and Lucille Van Geest Foundation and the National Institute for Health and Care Research Leicester Biomedical Research Centre. M.E. is an ICREA Research Professor., Peer reviewed